Orgenesis has agreed up to $50 million investment from Metalmark Capital in its US-based point of care services subsidiary, Morgenesis. The investment will consist of an upfront investment of $30 million and two future investments of $10 million each, subject to the achievement of certain milestones. Morgenesis will use the investment to develop and expand […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!